ALFA Finder| Metric | H2 FY26 | H1 FY26 | H2 FY25 |
|---|---|---|---|
| Revenue from operations | 64.9 | 45.8 | 47.2 |
| Other income | 1.3 | 1.4 | 1.6 |
| Total income | 66.2 | 47.2 | 48.9 |
| Profit before exceptional items & tax | 10.5 | 7.3 | 7.3 |
| Exceptional items | 0.6 | 0.0 | 0.0 |
| Profit before tax | 9.9 | 7.3 | 7.3 |
| Net profit | 6.9 | 5.5 | 5.5 |
| Operating margin | 15.0% | 15.5% | 14.9% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +25.50% |
|---|---|
| Net profit, quarter on quarter | +25.50% |
| Revenue, year on year | +37.50% |
NSE results filing, NSE: NEOCHEM. Figures extracted from the filing.
Neochem Bio Solutions Ltd: key numbers
- Share price
- ₹111.00
- Market cap
- ₹190.0 Cr
- Revenue (annual)
- ₹110.7 Cr
- Net profit (annual)
- ₹12.03 Cr
- P/E (TTM)
- 15.8×Sector 35.5×
- Promoter holding
- 66.88%
- FII holding
- 0.18%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Neochem Bio Solutions Ltd
All →Neochem Bio Solutions Earnings Call Transcript: Key Takeaways
Neochem Bio Solutions is a specialty chemical manufacturer reporting strong H1 FY25 growth, achieving ₹4,718 Lakh income with 18.75% EBITDA margin, focusing on Textile, HPC, and sustainable bio-based formulations.
Neochem Bio Solutions Investor Presentation: Key Takeaways
H1 FY27 revenue ₹68.9 cr (+50% y-o-y), PAT ₹7.8 cr (+43%), but EBITDA margin fell to 18.0% from 21.7%. Strategy centres on diversification and bio-based chemistries.
Neochem Bio Solutions Management Change
Neochem Bio Solutions appointed Harshit Shah as CFO and Vikram Nair as CCO effective October 27. Solanki was redesigned from CFO to Senior VP Finance.
Neochem Bio Solutions H1 FY27 Results: Net Profit ₹7.8 Cr, Up 41.8% YoY
Neochem Bio Solutions Ltd reported revenue from operations of ₹68.9 Cr (+50.4% YoY) and net profit of ₹7.8 Cr (+41.8% YoY) for H1 FY27.
- Key figure
- Net profit ₹7.8 Cr · +41.8% YoY
Neochem Bio Solutions Other Announcement
Neochem Bio Solutions Limited submitted its Structured Digital Database (SDD) compliance certificate for the quarter and half-year ended September 30, 2026, as per SEBI regulations.
Neochem Bio Solutions Annual General Meeting
Neochem Bio Solutions Limited held its 9th Annual General Meeting on September 21, 2026, where management reviewed the company's performance and discussed future business strategies.